2014

CreateTime:2020-03-19    View:1617
Pengyuan Liu
1.Kelly LM#, Barila G#, Liu P#, Evdokimova VN, Trivedi S, Panebianco F, Gandhi M, Carty SE, Hodak SP, Luo J, Dacic S, Yu YP, Nikiforova MN, Ferris RL, Altschuler DL, Nikiforov YE*. Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer. Proc Natl Acad Sci U S A. 2014;111(11):4233-8. 
Link: https://www.pnas.org/content/111/11/4233.abstract
2.Morrison CD#*, Liu P#, Woloszynska-Read A, Zhang J, Luo W, Qin M, Bshara W, Conroy JM, Sabatini L, Vedell P, Xiong D, Liu S, Wang J, Shen H, Li Y, Omilian AR, Hill A, Head K, Guru K, Kunnev D, Leach R, Eng KH, Darlak C, Hoeflich C, Veeranki S, Glenn S, You M, Pruitt SC, Johnson CS, Trump DL. Whole Genome Sequencing Identifies Genomic Heterogeneity at a Nucleotide and Chromosomal Level in Bladder Cancer. Proc Natl Acad Sci U S A. 2014;111(6):E672-81. 
Link: https://www.pnas.org/content/111/6/E672
3.Liu Y#, Liu P#, Yang C, Cowley AW*, Liang M*. Base-Resolution Maps of 5-Methylcytosine and 5-Hydroxymethylcytosine in Dahl S Rats: Effect of Salt and Genomic Sequence. Hypertension. 2014;63(4):827-38. 
Link:https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.113.02637
Institute of Translational Medicine, Zhejiang University
Address: 268 Kaixuan Road, Shangcheng District, Hangzhou City, Zhejiang Province
Tel: 0571-86971812 / 0571-88981576

Wechat Public